EXPLORE THE PRACTICE RESOURCE CENTRE – we are pleased to share the new PRC promotional video. In just over two minutes, we highlight the benefits of the site for seasoned practitioners and those just starting their career, how to easily submit ideas and resources, how to create a custom reading list, and much more.

Glaucoma OCT Interpretation is an online, Section 3 accredited course available at EyeCarePD.com. A game-based approach is applied to learning OCT interpretation. This course covers commonly encountered OCT presentations of glaucoma as seen on standard optic nerve head and retinal nerve fiber layer scan protocols with the purpose of improving interpretation skills using perceptual learning strategies.

Getting started is easy: 

1. Using the Google Chrome browser, navigate to https://eyecarepd.com/catalog/glaucoma-group/
2. Select Glaucoma OCT Interpretation 101 (COS Accredited) and add the product to the cart
3. At checkout, use the coupon code ECPDCOSGLAUCOMA to set the price to 0.
4. Your course is now available under My Courses at the top of the screen. 

Learning Objectives:

1. Identify segmentation errors and their role in OCT scan interpretation
2. Utilize varying sections of the OCT report including tabular data, sector analysis and graphical displays
3. Interact with expert interpretation in order to compare their findings in selected cases

Accreditation

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. This web-based lesson was approved by the COS on October 23rd, 2020 and expires October 2023. Remember to visit MAINPORT to record your learning and outcomes. You may claim a maximum of 1 hour (credits are automatically calculated).

This activity was co-developed with EyeCarePD and the Canadian Ophthalmological Society (COS) and was planned to achieve scientific integrity, objectivity and balance.

Access Details
To participate in this course visit https://eyecarepd.com/catalog/glaucoma-group/

Please note that this webinar has passed. A recording is available below.

October is Ergonomics Month and what better time to learn more about staying safe and healthy in your practice and personal life? Join us on Thursday, October 9, 2025 for an educational and lively discussion on Ergonomics and Injury Prevention.

Learn more from ergonomics experts Dr. Sam Masket, Clinical Professor of Ophthalmology (Retired), Geffen School of Medicine, UCLA and founding partner of Advanced Vision Care in Los Angeles, and Dr. Amy Zhang, Associate Clinical Professor of the Glaucoma Service at the University of Michigan Kellogg Eye Center. Moderated by Dr. R. Rishi Gupta, Chair of the COS Ergonomics and Injury Prevention Working Group, this accredited webinar will feature an interview-style presentation, practical and interactive “micro breaks” videos, and the premiere of our ergonomics video featuring ophthalmologist and COS Past President Dr. Dan O’Brien from Nova Scotia sharing his patient journey.

At the end of this webinar, participants will:

1. Understand the impact that musculoskeletal (MSK) disorders have on physician performance, job satisfaction and workforce limitations.
2. Understand the ergonomic problems associated with workplace equipment, such as operating microscopes, slit lamps, and indirect ophthalmoscopes.
3. Appreciate what modalities exist to reduce the impact of MSK disorders and how this subject should be part or Resident/Fellow education. 

Written by Pauline Calixte, 4th year medical student at University of Sherbrooke.

On October 9th, we recognize the importance of eye care.

Coordinated by the International Agency for the Prevention of Blindness (IAPB) and
supported by the World Health Organization (WHO), this global event aims to highlight
the importance of accessible, affordable, and quality eye care for all.

Approximately 2.2 billion people around the world live with some form of vision
impairment. Many of these conditions can be managed with early detection and proper
care, as nearly half of all cases are preventable or treatable.

Objectives:

• Raise awareness about the importance of eye health
• Draw government’s attention to the need for investment in accessible and affordable eye care
• Promote regular eye exams to prevent avoidable diseases

What you can do:

• Get your eyes tested and encourage others to do the same.
• Share your story on social media using hashtags like #WorldSightDay and LoveYourEyes
• Support organizations working in global eye health.

For more information, please visit the World Sight Day

References:

1. IAPB. World Sight Day [Internet]. IAPB; [cité le 3 octobre 2025]. Disponible à hIps://www.iapb.world/world_sight_day

2. Sightsavers. World Sight Day 2025 [Internet]. Sightsavers; 2025 [cité le 3 octobre
   2025]. Disponible à : hIps://www.sightsavers.org/world-sight-day/ Sightsavers

Recommended by Dr. R. Rishi Gupta, this Globe and Mail article offers an important reflection on physician wellness and the physical and mental toll of striving for excellence in medicine. It’s a meaningful read for anyone interested in ergonomics, balance, and sustainable practice.

On behalf of the COS Ergonomics and Injury Prevention Working Group and the Committee on Ophthalmology Residents Ergonomics Education, we are pleased to share with you the 2025–26 CORE Curriculum.

The attached CORE Curriculum Guide outlines six practical and easy-to-implement initiatives designed to promote ergonomic awareness and injury prevention among the residents in your program.

As October marks National Ergonomics Awareness Month, we encourage you to initiate the curriculum during this time. Should you have any questions, please feel free to reach out to any member of the CORE team. We appreciate your support in fostering resident wellbeing and a healthier ophthalmology workforce.

Warm regards,
CORE members:

Dr. Harald Gjerde

Dr. R. Rishi Gupta

Dr. Femida Kherani

Dr. Rookaya Mather

Created on July 16, 2021
Revised September 19, 2025

Visudyne is an essential therapeutic agent for the treatment of specific sight-threatening
retinal and choroidal diseases, including choroidal tumours, anti-VEGF resistant neovascular
age-related macular degeneration (nAMD) and central serous choroidopathy (CSC). There is
an active global shortage of Visudyne, and the next resupply is not expected to be available in
Canada until the end of June 2026 (see: www.drugshortagescanada.ca).

The Canadian Retina Society (CRS) and Canadian Ophthalmological Society (COS) are working
with Health Canada’s Drug Shortages Unit on this issue. Further, the CRS and the COS are
suggesting the following mitigation strategies and suggest that the remaining supply of
Visudyne be prioritized as follows:

• Priority 1: For the full course of treatment and management of sight threatening Ocular Tumours
• Priority 2: For the treatment of non-resolving CSC
• Priority 3: For the treatment of anti-VEGF resistant nAMD

The CRS and COS provide this information for guidance and urge all treating Ophthalmologists
to collaborate with their local and regional oncology and retinal specialist groups to ensure
careful triage of this agent to those patients in most dire need.

Date: Friday September 26

Time: 8:45 AM – 12:00 PM

Location: 45 Brunswick Ave., Multipurpose Room B, Toronto

Title: Eyelids

Speakers: Dr. Nancy Tucker

The VPP Grand Rounds Local and Visiting Professor Program is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Date: Friday September 26, 2025

Time: 7:30 AM – 8:30 AM

Title: The other EBM:  Evidence-based mentorship

Speaker: Dr. Sharon Straus

Zoom link: Register HERE

After registering, you will receive a confirmation email containing information about joining the webinar.

Objectives:

• Define mentorship
• Use a framework for developing mentorship
• Reflect on intersection of mentorship and equity, diversity, and inclusion

The VPP Grand Rounds Local and Visiting Professor Program is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. You will be able to claim 1 credit for this round.

Date:

Time:

Title: 

Speaker:

Zoom Link to Register:

Check back next week to view new information about DOVS Cornea Rounds!

The VPP Grand Rounds Local and Visiting Professor Program is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. You will be able to claim 1 credit for this round.

Upcoming Webinar

📅 Tuesday, October 14, 2025
⏰ 7:00–8:00 p.m. ET

Inherited Retinal Disorders: Progress, Promise, and Lessons Beyond Setbacks

Presented by Dr. Ioannis Dimopoulos, MD, MSc, FRCSC

Join us for an in-depth session as Dr. Dimopoulos explores the latest advancements in inherited retinal disease (IRD) research, emerging therapeutic approaches, and key lessons learned from clinical challenges.

Dr. Dimopoulos obtained his medical degree from the University of Athens and subsequently completed graduate studies and a research fellowship in Ocular Genetics at the University of Alberta. He was directly involved and lead the outcome measure assessment for an ocular gene therapy trial for choroideremia – the first in Canada. Following his ophthalmology residency training at the University of Ottawa, he completed a 2 -year fellowship in Medical Retina & Ophthalmic Genetics at the National Eye Institute / National Institutes of Health. He recently joined the University of Ottawa’s Department of Ophthalmology as an Assistant Professor. His clinical and research interests include inherited retinal disorders, gene therapy, AMD, CSCR, and diabetic retinopathy.

Learning Objectives:

By the end of the session, participants will be able to: 

1. Describe the genetic and clinical landscape of inherited retinal disorders (IRDs) and the associated unmet medical needs
2. Explain the principles, current applications, and clinical progress of gene therapy in retinal diseases, including the case of choroideremia
3. Discuss future directions, challenges, and emerging technologies in the development of gene therapy for IRDs.